Letter to the Editor: Lean-Body Mass-Guided Heparin Dosing: A Pharmacokinetic Imperative

Abstract

Get full access to this article

View all access options for this article.

References

Nguyen

Murray

Campbell-Bright

, et al. Adjusted versus total body weight dosing for intravenous heparin infusions and target attainment in obese patients. Hosp Pharm. Published online June 29, 2025. doi:10.1177/00185787251348377

Belančić

Al-Sallami

HS.

Spotlight commentary: changes in pharmacokinetics following significant weight loss. Br J Clin Pharmacol. 2025;91(3):678-680. doi:10.1111/bcp.16401

Al-Sallami

Newall

Monagle

Ignjatovic

Cranswick

Duffull

Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients. Br J Clin Pharmacol. 2016;82(1):178-84. doi:10.1111/bcp.12930

Derbalah

Duffull

Sherwin

Job

Al-Sallami

Optimal dosing of enoxaparin in overweight and obese children. Br J Clin Pharmacol. 2022;88(12):5348-5358. doi:10.1111/bcp.15459

Sinha

Duffull

Al-Sallami

HS.

A review of the methods and associated mathematical models used in the measurement of fat-free mass. Clin Pharmacokinet. 2018;57(7):781-795. doi:10.1007/s40262-017-0622-5